Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Oncology Sponsors choose UBC because of our depth and breadth of oncology expertise. We support your product’s entire lifecycle. Through clinical development, risk management strategies, and patient access and support, UBC has the streamlined, comprehensive service offerings you require.
Development of small molecules and antibodies that block signal transduction pathways and their cell surface receptors remains a critical focus for new cancer therapeutics. In addition, Basket trials and big data strategies have been critically important in efficient identification of significant clinical activity for these new molecules.
UBC has demonstrated extensive experience in these areas as well as experience in signal-seeking trials design. UBC will continue participation in these traditional clinical development avenues, but is excited to address emerging advances in cancer treatment. Areas of particular interest include:
Full Service Clinical Support to Meet Critical Needs
Post Approval and Safety Support to Meet Regulatory Needs